XML 198 R178.htm IDEA: XBRL DOCUMENT
v3.23.3

Merger Agreement with MedTech Acquisition Corporation (Details) - USD ($) $ / shares in Units, $ in Thousands | Nov. 11, 2022 | Dec. 31, 2022 | Dec. 31, 2021
--- | --- | --- | ---
Series A-1 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | $ 0.001 | $ 0.001
Series A-2 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series A-3 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series A-4 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series A-5 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series A-6 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series B preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series B-1 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series B-2 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | 0.001 | 0.001
Series B-3 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) |  | $ 0.001 | $ 0.001
TriSalus | MedTech Acquisition Corporation |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Aggregate consideration payable | $ 220,000 |  |
Warrants consideration | $ 220,000 |  |
Deferred expenses |  | $ 2,719 |
TriSalus | MedTech Acquisition Corporation | Series A-1 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | $ 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series A-2 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series A-3 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series A-4 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series A-5 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series A-6 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series B preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series B-1 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series B-2 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | 0.001 |  |
TriSalus | MedTech Acquisition Corporation | Series B-3 preferred stock |  |  |
Merger Agreement with MedTech Acquisition Corporation |  |  |
Convertible preferred stock, par value per share (in dollars per share) | $ 0.001 |  |

X
- Definition Amount of business acquisition cost deferred. + References No definition available. + Details
Name: | tlsi_BusinessCombinationAcquisitionExpensesDeferred
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of consideration for the warrants. + References No definition available. + Details
Name: | tlsi_BusinessCombinationWarrantsConsideration
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (27) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_TemporaryEquityParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA2ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA3ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA4ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA5ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesA6ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesBConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesB1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesB2ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=tlsi_SeriesB3ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tlsi_TrisalusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=tlsi_MedtechAcquisitionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |